Pathstone Family Office’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $41M | Buy |
336,521
+323,065
| +2,401% | +$39.4M | 0.31% | 48 |
|
|
2023
Q2 | $1.9M | Buy |
13,456
+1,234
| +10% | +$174K | 0.03% | 325 |
|
|
2023
Q1 | $1.72M | Sell |
12,222
-14,700
| -55% | -$2.07M | 0.03% | 313 |
|
|
2022
Q4 | $3.94M | Buy |
26,922
+2,350
| +10% | +$344K | 0.03% | 326 |
|
|
2022
Q3 | $3.02M | Buy |
24,572
+14,427
| +142% | +$1.77M | 0.03% | 321 |
|
|
2022
Q2 | $1.35M | Buy |
10,145
+550
| +6% | +$73.1K | 0.03% | 281 |
|
|
2022
Q1 | $1.31M | Sell |
9,595
-340
| -3% | -$46.5K | 0.03% | 261 |
|
|
2021
Q4 | $1.72M | Buy |
9,935
+268
| +3% | +$46.3K | 0.04% | 217 |
|
|
2021
Q3 | $1.41M | Buy |
9,667
+81
| +0.8% | +$11.8K | 0.04% | 218 |
|
|
2021
Q2 | $1.27M | Sell |
9,586
-1,052
| -10% | -$139K | 0.04% | 221 |
|
|
2021
Q1 | $1.37M | Buy |
10,638
+8,376
| +370% | +$1.07M | 0.05% | 167 |
|
|
2020
Q4 | $270K | Buy |
2,262
+2,238
| +9,325% | +$267K | 0.01% | 224 |
|
|
2020
Q3 | $3K | Hold |
24
| – | – | ﹤0.01% | 681 |
|
|
2020
Q2 | $3K | Hold |
24
| – | – | ﹤0.01% | 595 |
|
|
2020
Q1 | $2K | Buy |
+24
| New | +$2K | ﹤0.01% | 684 |
|
|
2019
Q4 | – | Sell |
-24
| Closed | -$3K | – | 473 |
|
|
2019
Q3 | $3K | Hold |
24
| – | – | ﹤0.01% | 550 |
|
|
2019
Q2 | $2K | Hold |
24
| – | – | ﹤0.01% | 585 |
|
|
2019
Q1 | $2K | Sell |
24
-1,676
| -99% | -$140K | ﹤0.01% | 754 |
|
|
2018
Q4 | $142K | Buy |
+1,700
| New | +$142K | 0.04% | 101 |
|